CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 3 enrolled
Drug / intervention
Nitrous Oxidedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03375294
NCT03375294Phase 2Completed
CompareCT.gov

Exploring Nitrous Oxide Effects for Post Traumatic Stress Disorder (PTSD)

Stanford University·interventional·Posted Dec 18, 2017·Updated Jul 24, 2020

In Brief

A Phase 2 clinical trial evaluating Nitrous Oxide for Post Traumatic Stress Disorder. Completed, enrolled 3 participants across 1 site.

Detailed Summary

The purpose of this study is to understand nitrous oxide effects in post traumatic stress disorder (PTSD)

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Traumatic Stress Disorder
CountriesUnited States
Collaborators--

Timeline

Phase 2CompletedFinished
201820192020202120222023202420252026
First PostedDec 18, 2017
Enrollment StartApr 1, 2018
Primary CompletionJul 31, 2019
Study CompletionApr 5, 2020
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.5 years ago

Interventions

Nitrous Oxidedrug

One hour inhalation of 50% nitrous oxide, an odorless, colorless gas FDA approved as an induction agent for dental sedation